Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-17

Clinical Trial Update: Bevacizumab Effect on Blood Velocity

View source ↗

Summary

A completed clinical trial evaluating how bevacizumab affects blood velocity in choroidal neovascularization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Optical Imaging, Ltd. | Conditions: Choroidal Neovascularization | Status: COMPLETED